Clinical Trial Update: Prevention of Taxane-associated Acute Pain Syndrome With Etoricoxib [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating etoricoxib for prevention of taxane-associated acute pain syndrome has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pain Syndrome

Drugs mentioned

• Etoricoxib (etoricoxib)

Snippet

Sponsor: Guangdong Provincial People's Hospital | Conditions: Pain Syndrome | Phase 2 | Status: COMPLETED